Introduction {#Sec1}
============

Carbohydrate microarrays provide a means of rapidly screening the interactions between glycans and other molecules \[[@CR1]--[@CR7]\]. Applications for this technology include the screening of protein--glycan interactions, characterization of carbohydrate-active enzymes and the analysis of the specificities of monoclonal antibodies (mAbs) and carbohydrate-binding modules \[[@CR8], [@CR9]\]. mAbs are powerful tools for investigating the biological roles of glycans but producing them is time consuming, labour-intensive and costly. Hybridoma-based mAb production involves the fusion of spleen cells from an immunized animal with myeloma cells. The resulting hybridoma cell lines are both immortal and secrete antibody into the cell supernatant \[[@CR10]\]. This procedure is conventionally performed in a one-by-one fashion, such that each animal is immunized with a single antigen and the resulting antibodies are screened for desired specificities using enzyme-linked immunosorbent assays (ELISAs). However ELISA-based screening is low throughput because only a limited amount (∼100 μl) of hybridoma supernatant is available for screening during the initial stages of mAb production and this is typically only sufficient to test each mAb against just one or two antigens. An alternative approach involves 'shotgun' immunisation with a mixture of antigens \[[@CR11]\]. This potentially results in the simultaneous generation of antibodies with a range of specificities, but the time limiting step then becomes the detailed retrospective screening of their specificities. However, microarrays offer a means of rapidly screening limited amounts of hybridoma supernatant against multiple antigens and therefore greatly increasing throughput in the identification of valuable cell lines. Here we report the use of shotgun immunisation followed by microarray-based screening of hybridoma supernatants in order to produce mAbs against plant cell wall glycans.

Plant cell walls are fibre composites that contain some of the most complex glycans known \[[@CR12], [@CR13]\]. In addition to their biological roles, many cell wall components have important industrial applications including as functional food ingredients, pharmaceuticals, nutriceuticals, fibres and increasingly, bio-fuels \[[@CR14]--[@CR16]\]. Cell wall glycans can be broadly grouped into cellulose, hemicelluloses, pectins and glycoproteins \[[@CR17]\]. Cellulose microfibrils are cross-linked by hemicelluloses such as xyloglucans, xylans and mixed linkage glucans forming a tough load-bearing matrix which is embedded in pectic polysaccharides \[[@CR18]\]. Pectins are the most complex and heterogeneous family of cell wall glycans and are comprised of a series of galacturonic acid-rich polymers including homogalacturonan (HG), rhamnogalacturonan I (RGI), rhamnogalacturonan-II (RG-II) and xylogalacturonans (XG). In addition, structurally complex arabinan, galactan and arabinogalactan polymers may be present as side chains to the galacturonan-rich backbone domains \[[@CR18]\]. The protein moieties of cell wall glycoproteins are often rich in hydroxyproline (Hyp) and these polymers, which are collectively referred to as Hyp-rich glycoproteins (HRGPs), include the extensins and arabinogalactan-proteins (AGPs) \[[@CR19]--[@CR21]\].

The fine structures and relative amounts of cell wall components vary greatly not only among plants, but also between organs, tissues, cells, and even between different micro-domains within a single cell wall. This complexity and heterogeneity presents a major barrier to detailed analysis and our understanding of many aspects of plant cell wall structure and function is far from complete. Several mAbs with specificities for diverse plant cell wall components have been developed and these are powerful tools for the analysis of cell walls \[[@CR22]\]. However, the repertoire of mAbs currently available covers only a small proportion of the glycan structures that have been identified and there is a pressing need for a wider range of mAbs to facilitate the further characterization of cell walls. We have developed a method of rapidly screening mAb specificities using microarrays of cell wall glycans including pectins with different degrees and patterns of methyl-esterification, pectic side chains (*e.g.* arabinan and galactan), hemicelluloses (*e.g.* xylans, mannans, and xyloglucans), HRGPs (*e.g.* AGP-rich gums), β-linked glucans (*e.g.* (1→3)(1→4)-β-glucan and (1→3)-β-glucan) and celluloses (*e.g.* hydroxylethyl cellulose and carboxylmethyl cellulose). A further 14 samples were sequentially extracted from *A. thaliana* using CDTA and NaOH which are known to predominately solublize pectic polymers and hemicelluloses respectively \[[@CR23]\].

Experimental procedures {#Sec2}
=======================

Immunisation and generation of monoclonal hybridomas {#Sec3}
----------------------------------------------------

Cell wall polymers were isolated from 6 week old wild type *A. thaliana* plants, ecotype Col-0, grown in soil at 22°C with cycles of 10 h of light/14 h of darkness. One g dry weight of a mixture of leaves, stems and roots was homogenized to a fine powder in liquid nitrogen. The homogenate was incubated with 20 ml 50 mM 1,2-Diaminocyclohexanetetraacetic acid (CDTA; pH 7.5) for 3 h at 18°C and centrifuged for 20 min at 4,400 rpm. The supernatant was collected and dialyzed extensively against deionized water (dH~2~O) in dialysis tubing (6--8,000 kDa molecular weight cut off) to remove low molecular weight molecules and freeze dried. The material was dissolved in phosphate-buffered saline (PBS) to generate the immunogen. Rats were used for antibody production so as to make subsequent comparisons with existing mAbs, most of which were produced in rats, as valid as possible. The immunization of rats, hybridoma preparation and cloning procedures were as described previously \[[@CR24]\]. Briefly, two male Wistar rats were each injected subcutaneously with 250 μl of an emulsion of the isolated cell wall material at 1 mg/ml in PBS with an equal volume Freund's complete adjuvant on day 0. On days 40 and 79 the injections were repeated using incomplete adjuvant. Tail bleeds were taken 10 days after injections to assess the immune response. On day 198 a pre-fusion boost was given to the selected rat and 3 days later, the spleen was removed and lymphocytes were isolated and fused with rat myeloma cell line IR983F \[[@CR25]\] using standard polyethylene glycol fusion of lymphocytes and myeloma cells. Hybridoma lines were initially screened by ELISA with the immunogen coated onto microtitre plates (MaxiSorp, Nunc, Roskilde, Denmark) at 50 μg/ml.

Previously described monoclonal antibodies {#Sec4}
------------------------------------------

Arrays were probed with 23 mAbs with previously described specificities and details of these are provided in Table [1](#Tab1){ref-type="table"}. All were rat antibodies except mAbs CCRC-M1, BS-400-02, BS-400-03, and BS-400-04 which were produced in mice and PAM1 which was produced by phage display. Table 1Previously characterized monoclonal antibodies used to probe glycan arrays. HG, homogalacturonanSpecificityNameRef.Un-esterified HGPAM1\[[@CR31]\]Un-esterified/Calcium ion cross-linked HG2F4\[[@CR34]\]Partially methyl-esterified HGJIM5\[[@CR33]\]Partially methyl-esterified HGJIM7\[[@CR33]\](1→4)-β-galactanLM5\[[@CR37]\](1→5)-α-arabinanLM6\[[@CR24]\]Fucosylated xyloglucanCCRC-M1\[[@CR38]\]Non-fucosylated xyloglucanLM15(1→4)-β-mannan/galacto-(1→4)-β-mannanBS-400-4\[[@CR39]\](1→4)-β-xylanLM10\[[@CR40]\](1→3)(1→4)-β-glucanBS 400-3\[[@CR41]\](1→3)-β-glucanBS 400-2\[[@CR32]\](1→4)-β-xylan/arabinoxylanLM11\[[@CR40]\]Arabinogalactan-proteinJIM4\[[@CR43]\]Arabinogalactan-proteinLM2\[[@CR42]\]Arabinogalactan-proteinMAC207\[[@CR43]\]Arabinogalactan-proteinJIM8\[[@CR44]\]Arabinogalactan-proteinJIM13\[[@CR43]\]Arabinogalactan-proteinJIM16\[[@CR43]\]Arabinogalactan-proteinJIM14\[[@CR43]\]ExtensinLM1\[[@CR45]\]ExtensinJIM19\[[@CR46]\]ExtensinJIM20\[[@CR46]\]

Glycan samples used on the array {#Sec5}
--------------------------------

Details of the 50 defined glycans used are provided in Table [2](#Tab2){ref-type="table"}. Most glycans were dissolved in dH~2~O. Arabinoxylan and glucuronoxylan were prepared by boiling in dH~2~O for 10 min. and then standing for 3 h at 18°C before use. Glucomannan was prepared by wetting with 95% ethanol followed by addition of dH~2~O. The mixture was heated to boiling point and stirred for 20 min until dissolved. Pachyman was prepared by dissolution in a minimal volume of 10% (*w*/*v*) sodium hydroxide followed by neutralization with acetic acid. 14 samples on the arrays were cell wall polymers extracted from *A. thaliana* organs listed in Table [2](#Tab2){ref-type="table"} using CDTA and 4 M NaOH. Fifty milligrams (fresh weight) of each organ collected from at least four separate plants were homogenized to a fine powder prior to adding 300 μl of 50 mM CDTA (pH 7.5). After incubating with rotation for 4 h at 20°C, the extracts were centrifuged at 4,400 rpm for 10 min and the supernatants ('CDTA extracts') removed. Pellets were resuspended in 300 μl of 4 M NaOH and samples were incubated with rotation for 4 h at 20°C prior to centrifugation at 4,400 rpm for 10 min. Supernatants were 'NaOH extracts'. Table 2Samples included on the glycan arraysAlphanumerical codesSamples**A1**Arabinan (sugar beet)**B1**Pectin (apple)**C1**Galactan (lupin)**D1**Homogalacturonan (sugar beet)**E1**Pectin (lime) B15**F1**Pectin (lime) B43**G1**Pectin (lime) B71**H1**Pectin (lime) 96**A2**Pectin (lime) F11**B2**Pectin (lime) F19**C2**Pectin (lime) F43**D2**Pectin (lime) F76**E2**Pectin (lime) P16**F2**Pectin (lime) P24**G2**Pectin (lime) P32**H2**Pectin (lime) P41**A3**Pectin (lime) P46**B3**Pectin (lime) P60**C3**Pectin (lime) P76**D3**RGI (soybean)**E3**RGII (*A. thaliana*)**F3**Xylogalacturonan (pea)**G3**MHR I (apple)**H3**MHR II (carrot)**A4**MHR III (potato)**B4**MHR HS1 (apple)**C4**MHR HS2 (apple)**D4**Xylogalacturonan (apple)**E4**AGP *(P. patens)***F4**Seed mucilage (*A. thaliana*)**G4**Xyloglucan/mannan (tomato)**H4**Glucomannan (konjac)**A5**Gum (guar)**B5**Gum (locust bean)**C5**Gum arabic (acacia)**D5**Gum (karaya)**E5**Gum (tragacanth)**F5**AGP (larch)**G5**Arabinoxylan (wheat)**H5***β*(1-3),(1-4)-glucan (lichenan)**A6**Mannan (ivory nut)**B6**Xyloglucan (tamarind)**C6**Glucuronoarabinoxylan (maize)**D6**Hydroxyethyl cellulose**E6***β*(1-4)-glucan (avicel)**F6**Carboxymethyl cellulose**G6**Alginic acid**H6***β*(1-3),(1-6)-glucan (laminarin)**A7***β*(1-3)-glucan (pachyman)**B7***β*(1-4),(1-6)-glucan (pullulan)**C7**CDTA extract (*A. thaliana* flowers)**D7**CDTA extract (*A. thaliana* siliques)**E7**CDTA extract (*A. thaliana* stem top)**F7**CDTA extract (*A. thaliana* stem middle)**G7**CDTA extract (*A. thaliana* stem base)**H7**CDTA extract (*A. thaliana* leaves)**A8**CDTA extract (*A. thaliana* roots)**B8**NaOH extract (*A. thaliana* flowers)**C8**NaOH extract (*A. thaliana* siliques)**D8**NaOH extract (*A. thaliana* stem top)**E8**NaOH extract (*A. thaliana* stem middle)**F8**NaOH extract (*A. thaliana* stem base)**G8**NaOH extract (*A. thaliana* leaves)**H8**NaOH extract (*A. thaliana* roots)Alphanumerical codes refer to the position of samples on arrays. Source organisms are in parentheses*RGI* Rhamnogalcturonan I; *RGII* rhamnogalacturonan II; *MHR* modified hairy region; *AGP* arabinogalactan-protein

Post-printing modification of glycans {#Sec6}
-------------------------------------

Glycan samples on selected arrays were modified *in situ* after printing by enzymatic digestion. For the data in Fig. [6](#Fig6){ref-type="fig"} selected arrays were digested with endo-*α*(1-5)-L-arabinanase or endo-*β*(1-4-)-galactanase (both from *Aspergillus niger*, Megazyme (Bray, Ireland) used at 1 U/ml in 200 mM sodium acetate pH 4.0.

Printing of arrays {#Sec7}
------------------

Glycans were applied to nitrocellulose membrane (0.45 μm pore size, Schleicher and Schuell, Dassel, Germany) at two concentrations (0.2 and 0.04 mg/ml) and in duplicate such that each sample was represented by four spots. CDTA and NaOH extracted *A. thaliana* material was printed as extracted and as a five fold dilution, also in duplicate. Printing was performed using a microarray robot (Microgrid II, Genomic Solutions, Ann Arbor, MI, USA) equipped with split pins (MicroSpot 2500, Genomic Solutions). Pins were washed twice in dH~2~O after deposition of each sample.

Probing of arrays {#Sec8}
-----------------

Arrays were blocked by incubation for 1 h in PBS (140 mM NaCl, 2.7 mM KCl,10 mM Na~2~HPO~4~, 1.7 mM KH~2~PO~4~, pH 7.5) containing 5% *w*/*v* low fat milk powder (5%MPBS). Arrays were then probed for 2 h with antibodies diluted in 5%MPBS. All antibodies were used as 1/10 dilutions except CCRC-M1 which was used at 1/50, and BS-400-2, BS-400-3 and BS-400-4 which were used at 1/200. After washing with PBS, arrays were incubated for 2 h in either anti-rat or anti-mouse secondary antibody conjugated to alkaline phosphatase (Sigma, Poole, UK) diluted 1/5000 in 5%MPBS. After washing in PBS, arrays were developed using a substrate containing 5-bromo,4-chloro,3-indolylphosphate (BCIP) and nitroblue tetrazolium (NBT) in BCIP/NBT buffer (100 mM NaCl, 5 mM MgCl~2~, 100 mM diethanolamine, pH 9.5).

Scanning and analysis {#Sec9}
---------------------

Arrays were scanned, converted to 16 bit grey-scale TIFFs, transformed to negative images and uploaded into ImaGene 6.0 microarray analysis software (BioDiscovery, El Segundo, CA, USA). Semi-automatic gridding was used to create an analysis area for each spot, and a 5-pixel zone around each spot was used for calculation of local background signals. Individual spot signals were defined as the mean pixel value within each spot area (red zone in Fig. [1](#Fig1){ref-type="fig"}d) minus the median pixel value in the surrounding local background area (green zone in Fig. [1](#Fig1){ref-type="fig"}d). The mean of the four individual spot signals for each sample was defined as the 'mean sample value' (MSV) and 'total mean sample values' (TMSVs) were the means of MSVs from three separate experiments. Selected data sets (TMSVs) were used to generate heatmaps (Figs. [2](#Fig2){ref-type="fig"}b and [5](#Fig5){ref-type="fig"}b) using online heatmapper software (<http://bbc.botany.utoronto.ca/ntools/cgi-bin/ntools_heatmapper.cgi>). For each antibody in the heatmap, the maximal TMSV was set to 100% and all other values within that data set adjusted accordingly. A cut off of 5% of the maximal TMSV was imposed. Hierarchical cluster analysis was performed on TMSVs obtained for 23 previously characterized antibodies and 7 newly produced ones using Epclust software (<http://ep.ebi.ac.uk/EP/EPCLUST/>). Clustering was based on correlation measure based distance and average linkage. Fig. 1Microarrays of plant cell wall glycans. **a**, **b** A library of 50 glycan polymers were spotted onto nitrocellulose membranes in an area 22 mm × 22 mm. Arrays included pectins, HRGPs, hemicelluloses and glucans (samples, A1--B7) and the position of these classes of polymer on the arrays are indicated by colour coding in (**b**). Fourteen samples extracted from *Arabidopsis thaliana* using either CDTA (samples C7--A8) or NaOH (samples B8--H8), were also included. Details of the samples are provided in Table [2](#Tab2){ref-type="table"}. **c** Each sample was printed at the two concentrations indicated and in duplicate. **d** Microarray analysis software (ImaGene 6.0) was used to quantify spot signals and individual spot signals were defined as the mean pixel value within each spot area (*red zone*) minus the median pixel value in the surrounding local background area (*green zone*). **e**--**g** Two pairs of three arrays were printed and probed with the anti-homogalacturonan mAb JIM5 on three separate occasions. The mean sample values (MSVs) for each pair were quantified and plotted against MSVs of an array produced on a different occasion. These are presented as scatter plots, with the *R*^*2*^-values for the plots indicatedFig. 2Probing of cell wall glycan arrays with mAbs with known specificities. **a** Glycan arrays were probed with 23 mAbs with previously defined specificities and 5 representative examples are shown: PAM1 (anti-homogalacturonan); BS-400-2 (anti-(1→3)-β-glucan; LM5 (anti-(1→4)-β-galactan); JIM13 (anti-arabinogalactan-protein); JIM5 (anti-homogalacturonan). A control array was probed with secondary antibody, but no primary mAb. Arrays were scanned and converted into 16 bit greyscale TIFFs. **b** Heatmap showing the total mean sample values (TMSVs) for the binding of each mAb to each sample. The maximal TMSV for each mAb was set to 100 and all other values were adjusted accordingly. A cut off of 5% of the maximal TMSV was imposed and all values at, or below this are represented as *black boxes*

Indirect immunofluorescence labeling of plant materials {#Sec10}
-------------------------------------------------------

Resin embedded and fresh plant material was sectioned and labelled with antibodies as described previously \[[@CR26], [@CR27]\]. LM14 and LM13 hybridoma supernatants were used as 1/10 dilutions in 5%MPBS. Sections were counterstained for cellulose with Calcofluor white (fluorescent brightener 28, Sigma, Poole, UK) used as a 0.005% aqueous solution.

Competitive-inhibition ELISA assays {#Sec11}
-----------------------------------

The ability of arabinose, galactose, rhamnose and oligoarabinosides to inhibit the binding of LM14 and LM13 to the immuogen in ELISAs was assessed as described previously \[[@CR28]\].

Sugar composition analysis of modified pectic hairy regions (MHRs) {#Sec12}
------------------------------------------------------------------

Sugar composition was determined using methanolysis as described previously \[[@CR29]\]. MHRs were treated with 2 N HCl in dry methanol for 16 h at 80°C, followed by 1 h of 2 M CF~3~CO~2~H (TFA) at 121°C. The released sugars were analysed using high-performance anion exchange chromatography (HPAEC) with pulsed amperometric detection (PAD) as described previously \[[@CR30]\].

Results {#Sec13}
=======

Production of microarrays of plant cell wall polymers {#Sec14}
-----------------------------------------------------

The layout of the arrays is shown in Fig. [1](#Fig1){ref-type="fig"} and colour coding indicates the distribution on the arrays of different classes of cell wall polymer (Fig. [1](#Fig1){ref-type="fig"}a,b). A detailed list of the samples used is provided in Table [2](#Tab2){ref-type="table"}. Each sample was represented on the arrays by four spots (two concentrations, printed in duplicate) (Fig. [1](#Fig1){ref-type="fig"}c) and microarray analysis software was used to quantify background-corrected spot signals (Fig. [1](#Fig1){ref-type="fig"}d). As shown by the arrays in Figs. [2](#Fig2){ref-type="fig"}a and [3](#Fig3){ref-type="fig"}, the consistency of the printing and probing replicates within arrays was high. However, reproducibility between arrays was also tested. A total of six arrays (3 × 2 pairs) were printed and probed with the anti-HG mAb JIM5 on three separate occasions. The MSVs were quantified and the values for each array were plotted against those from an array produced on a different occasion. The *R*^*2*^-values obtained for these plots were all \>0.98, indicating a high degree of reproducibility between arrays (Fig. [1](#Fig1){ref-type="fig"}e--g). Fig. 3Probing of cell wall glycan arrays with newly produced mAbs. Glycan arrays were probed with mono- or multiclonal antibodies generated following shotgun immunisation with plant cell wall polymers. Four representative examples are shown. Arrays were scanned and converted into 16 bit greyscale TIFFs

Probing of plant cell wall glycan arrays {#Sec15}
----------------------------------------

Arrays were probed with a range of mAbs with previously defined specificities for epitopes occurring on the major classes of cell wall polymers. Details of the mAbs used are provided in Table [1](#Tab1){ref-type="table"}. A total of 23 mAbs were tested and 5 representative examples are shown in Fig. [2](#Fig2){ref-type="fig"}a. The TMSVs for the binding of these mAbs to each sample (derived from three independent experiments) are shown as a heatmap in Fig. [2](#Fig2){ref-type="fig"}b, where spot signals are correlated to colour intensity. mAb binding profiles were in good agreement with the published results for the antibodies tested. For example, mAb PAM1 has specificity for HG with a low degree of methyl-esterification (DE) \[[@CR31]\] and consistent with this, PAM1 bound to lime pectin samples with DEs of 11--19% (samples E1, A2 and B2). PAM1 did not bind above background to other pectin samples with higher DEs, or to any other cell wall glycans. mAb BS-400-2 is specific for (1→3)-β-glucan \[[@CR32]\] and, of the defined samples, only bound to this polymer (sample A7) on the arrays. (1→3)-β-glucan is known to be extractable from plant cell walls using NaOH and consistent with this, BS-400-2 also bound to weakly to NaOH-solubilized extracts from *A. thaliana* (samples B8-H8). As expected, the epitopes recognized by some mAbs were detected on multiple samples and this was the case for mAbs LM5 (anti-(1→4)-β-galactan), JIM13 (anti-AGP) and JIM5. However, the binding profiles of these mAbs were also consistent with their known specificities. For example, JIM5 bound with greatest avidity to pectin samples that contained abundant HG domains (such as the lime pectins E1-C3), but not to pectic fragments lacking HG (such as the arabinan or galactan samples A1 and C1).

To generate a new series of cell wall-directed mAbs, rats were immunized with an immunogen consisting of a crude extract of cell wall material solubilized from *A. thaliana* using CDTA. 13 cell lines were selected by an initial ELISA analysis against the immunogen and these were subsequently probed against the cell wall polymer arrays and four representative examples are shown in Fig. [3](#Fig3){ref-type="fig"}. Antibodies that bound with very low avidity, or appeared to have identical binding profiles to previously generated antibodies were not selected for further analysis whilst the data for the remaining seven were subjected to hierarchical cluster analysis.

Hierarchical clustering of antibody binding profiles {#Sec16}
----------------------------------------------------

Cluster analysis was used to rapidly obtain information about the specificities of 7 new antibodies based on the similarly of their binding profiles on the arrays to 23 previously characterized mAbs (Fig. [4](#Fig4){ref-type="fig"}). Clustering indicated that most of the antibodies tested separated into 4 broad clusters: HG-binders; pectic side chain-binders; HRGP-binders and hemicellulose-binders. Three antibodies with specificity for (1→3)(1→4)-β-glucan, (1→3)-β-glucan and (1→4)-β-mannan did not cluster with any other mAbs within the 0.55 (distance measurement units) cut off imposed. These broad clusters were in agreement with the previously defined specificities of the mAbs tested, and this was also the case within sub-clusters. For example, within the HG-binders cluster, mAbs JIM5 and JIM7, which both bind to partially methyl-esterified HG \[[@CR33]\], clustered closely, whilst mAbs 2F4 and PAM1, which both bind to non-methyl-esterified HG also clustered closely \[[@CR31], [@CR34]\]. Similarly, within the hemicellulose-binders, the anti-xylan mAbs LM10 and LM11 formed a sub-cluster, as did the two anti-xyloglucan mAbs CCRC-M1 and LM15. One of the new mAbs (1H12, designated LM13 when cloned) was grouped with the pectic side chain-binders LM5 (anti-(1→4)-β-galactan) and LM6 (anti-(1→5)-α-arabinan). However, most of the new antibodies tested were grouped in the HRGP-binders cluster and within this, clustered most closely with the anti-AGP mAbs MAC207, JIM4 and JIM16. One of the new mAbs within this group (1B3, designated LM14 when cloned) was, together with LM13 subject to more detailed epitope characterization in order to further explore the evidence gained from the clustering analysis. Fig. 4Cluster analysis of antibody binding profiles to arrays. 23 mAbs with previously defined specificities, and 7 newly produced antibodies (*red diamonds* in *black boxes*) were analyzed using Epclust software. Hierarchical clustering was performed using clustered correlation measure based distance and average linkage. The binding profiles of all the mAbs analyzed clustered into four broad groups: *1* homogalacturonan-binders; *2* pectic side chain-binders; *3* HRGP-binders; and *4* hemicellulose-binders. Three mAbs were non-clustering outliers (NCO). The specificities of the 23 previously defined mAbs are listed in Table [1](#Tab1){ref-type="table"}

Detailed characterization of the epitopes recognized by LM14 and LM13 {#Sec17}
---------------------------------------------------------------------

Cluster analysis of LM13 and LM14 suggested that the epitopes recognized by these mAbs may contain neutral sugars such as arabinose and galactose, that are abundant in the side chains of both pectins and HRGPs. The glycan arrays contained five 5 samples of branched (or 'hairy') regions of pectic polymers modified by enzymatic digestion ('modified hairy regions' or MHRs) that were rich in neutral sugars and for which monosaccharide composition was determined (Fig. [5](#Fig5){ref-type="fig"}). The binding of LM14 and LM13 to these samples was therefore of particular interest. LM14 bound only to an MHR from carrot (sample H3), whilst LM13 bound to MHRs from potato and apple (samples G3, A4 and B4). It was noteworthy that the two MHR samples to which LM13 did not bind (samples H3 and C4) had the lowest arabinose content, suggesting that the epitope recognized by this mAb may contain arabinose. In order to explore this possibility further, the sensitivity of the LM13 epitope to arabinanase digestion was investigated. To do this, cell wall glycan microarrays were digested with arabinanase prior to probing with mAbs, and the TMSVs obtained with and without digestion were compared. These data are presented as scatter plots (Fig. [6](#Fig6){ref-type="fig"}a--d) in which signals from enzyme treated arrays were plotted against signals from untreated arrays. As a positive control, arabinanase digested and untreated arrays were probed with the anti-(1→5)-α-arabinan mAb LM6 \[[@CR24]\]. As expected, the binding of LM6 to all samples was reduced to some extent by arabinanase digestion (Fig. [6](#Fig6){ref-type="fig"}a). However, the effect of arabinanase digestion on LM13 binding was even more pronounced than for LM6 and LM13 binding to all samples on the arrays was essentially abolished (Fig. [6](#Fig6){ref-type="fig"}b). This suggested that the epitope recognized by LM13 either contained arabinan and was degraded by arabinanase, or that the epitope was attached to arabinan and was released from arrays by arabinanase. In contrast, LM14 binding to all samples was essentially unaffected by arabinanase digestion (Fig. [6](#Fig6){ref-type="fig"}c). The effect of galactanase digestion on mAb binding to arrayed samples was also assessed. LM13 binding was reduced to some extent by galactanase digestion, but the reduction was far less for than arabinanase digestion (Fig. [6](#Fig6){ref-type="fig"}d). LM14 binding to all samples was unaffected by galactanase digestion, and the ability of this enzyme to degrade galactan was indicated by the fact that the binding of the anti-(1→4)-β-galactan mAb LM5 was essentially abolished by galactanase digestion (data not shown). The epitope recognized by LM13 was further characterized using competitive inhibition ELISA (ciELISA) assays (Fig. [6](#Fig6){ref-type="fig"}e). The binding of LM13 to immobilized arabinan was inhibited to 50% of maximal binding by approximately 450 μg/ml of both arabino-*α*1,5-octaose and arabino-*α*1,5-pentaose, but oligoarabinosides of lower degrees of polymerisation and rhamnose, galactose and glucuronic acid failed to inhibit binding at the highest concentration tested of 1 mg/ml;. The binding of LM14 to immobilized antigen was not inhibited by any of the haptens tested at concentrations up to 1 mg/ml (data not shown). Fig. 5Binding of LM13 and LM14 to samples to pectic modified hairy regions (MHRs). **a** Monosaccharide composition of 5 pectin modified hairy regions (MHRs) from apple (samples G3, B4 and C4), carrot (sample H3), potato (sample A4). **b** TMSVs for the binding of mAbs LM14 and LM13 to these samples. The maximal TMSV for LM13 and LM14 (to all samples on the array) was set to 100 and all other values adjusted accordingly. A cut off of 5% of the maximal TMSV was imposed and all values at, or below this are represented as *black boxes*Fig. 6The epitope recognized by LM13 is arabinanase sensitive. **a**--**d** Scatter plots showing the effect of galactanse and or arabinanase on the binding of LM13, LM14 and LM6 (anti-(1→5)-α-arabinan) to glycan arrays. Arrays were incubated in enzymes after blocking but before probing. TMSVs were determined and plotted against each other. Spots that lie on the *dotted line* indicate that enzyme digestion had no effect on mAb binding, whereas spots that lie below the dotted line indicate where enzyme digestion reduced mAb binding. **e** The binding of LM13 to oligoarabinosides was tested by competitive inhibition ELISA, in which arabinan was the immobilized polymer. Oligoarabinosides with degrees of polymerization less than five failed to inhibit LM13 binding, even when used at 1 mg/ml. Both arabino-*α*1,5-octaose and arabino-*α*1,5-pentaose inhibited the binding of LM13 by 50% of maximal binding when used at approximately 450 μg/ml

Cluster analysis suggested that LM13 was most similar to that of mAbs with specificity for pectic side chains, whilst the binding of LM14 was most similar to that of anti-AGP mAbs. AGPs can be distinguished from pectic polymers using SDS-PAGE because whereas AGPs resolve as characteristic smears, pectic polymers typically do not enter gels \[[@CR35]\]. Western blots were prepared using the same *A. thaliana* CDTA-extracted material that was used for immunisation and probed with LM13 or LM14 (Fig. [7](#Fig7){ref-type="fig"}). LM13 did not bind to material on these blots whereas LM14 bound to a high molecular weight smear (∼70--200 kDa) that is characteristic of AGPs. Fig. 7Immunoblot of monoclonal antibodies LM13 and LM14. The CDTA-soluble *Arabidopsis thaliana* fraction that was used as the immunogen was separated by SDS-PAGE with 30 μg protein loading per lane. A Western blot of this material was probed with LM13 and LM14. LM13 did not bind to the blot but LM14-probing produced a smear in the region of 70--200 kDa, which is characteristic of AGPs

Immunolocalization of the LM14 and LM13 epitopes {#Sec18}
------------------------------------------------

In order to further investigate the epitopes recognized by LM13 and LM14 *in planta* a range of plant materials were probed with these mAbs using indirect immunofluorescence labelling. In transverse resin-embedded sections of *A. thaliana* inflorescence stems, LM13 bound specifically to epidermal cells and most strongly to the tangential cell walls (Fig. [8](#Fig8){ref-type="fig"}a). Plant cell wall glycans may be altered during extraction and/or immobilization such that epitopes are changed from their native state *in planta*. In order to test if this was a factor in determining the arabinase sensitivity of the LM13 epitope, sections of *A. thaliana* stems were also digested with arabinanase prior to probing with LM13. As shown by comparison of Fig. [8](#Fig8){ref-type="fig"}a,b, the binding of LM13 to *A. thaliana* stem epidermal cell walls was abolished following arabinanase digestion indicating that the epitope-structure immobilised on arrays recognized by LM13 reflected that observed *in planta*. In contrast to LM13, LM14 bound to some extent to all cell walls in an equivalent section through an *A. thaliana* stem (Fig. [8](#Fig8){ref-type="fig"}d). Labelling of the surface of intact roots of *A. thaliana* seedlings indicated that LM13 bound very weakly whereas LM14 bound strongly to the surface of root hairs (Fig. [8](#Fig8){ref-type="fig"}e and f). In transverse sections through tobacco stems, the LM13 epitope was associated with cell walls adjacent to metaxylem cells of the vascular tissue---a distinctly different labelling pattern to that observed in *A. thaliana* stems (Fig. [8](#Fig8){ref-type="fig"}g). In contrast, LM14 did not label any cell walls in tobacco stems (Fig. [8](#Fig8){ref-type="fig"}h). Fig. 8Indirect immunofluorescence labelling of plant material with LM14 and LM13. LM13 bound strongly to inner and outer radial walls of epidermal cells in transverse sections of *A. thaliana* inflorescence stem sections. The section is counterstained with calcofluor (*blue*) that labels β-linked glucans. **b** LM13 binding to *A. thaliana* inflorescence stem sections when sections were treated with arabinanase. *Arrowheads* in **a** and **b** indicate the epidermal surface. **c** Control in which an equivalent stem to that in **a** was labelled with the absence of primary antibody. **d**, An equivalent section to that shown in **a** labelled with LM14 which bound to all cell walls. **e** LM13 bound very weakly to the intact surface of the roots of *A. thaliana* seedlings. **f** LM14 bound strongly to the surface of root hairs (*arrowheads*) of Arabidopsis seedling roots. **g** In transverse sections through tobacco stem LM13 bound strongly to cell walls adjacent to files of metaxylem cells (*mx*). **h** LM14 did not bind to equivalent sections through tobacco stems. Scale bars = 50 μm for **a**--**d**, **g** and **h**; 20 μm for **g** inset, 50 μm for **e** and **f**

Discussion {#Sec19}
==========

The work presented here demonstrates the potential of glycan microarrays for overcoming a major bottleneck in anti-glycan mAb production. Specifically, the use of microarrays enabled 50 μl of hybridoma supernatant to be screened rapidly and simultaneously against \>60 potential epitope-bearing target molecules. A novel aspect of this work was the use of cluster analysis of array data to rapidly predict antibody specificities by comparison with previously defined mAbs. Subsequent detailed analyses of the specificities of the new mAbs LM13 and LM14 indicated they bound to pectic and AGP class of polymers respectively, as was predicted by the cluster analysis. These results indicate that if a relatively large set of probes with defined specificities are available to serve as references, this is an effective method for high-throughput initial mAb screening. One potential limitation of shotgun immunisation could be immuno-dominance, such that an immune response is elicited against a limited subset of the injected antigens. In this study two mAbs, LM13 and LM14 were selected with specificity for two different classes of molecule. However, of the seven mAbs selected for cluster analysis of binding profiles, six clustered with mAbs with specificity for AGPs and one with mAbs to pectic side chains, suggesting that AGPs were the immuno-dominant antigens in this case. It is therefore likely that such a multi-antigen approach towards cell wall polymers may be most effective to obtain a panel of mAbs with a range of specificities within a single class of polymer.

The arrays we constructed were based on the non-covalent attachment of glycans to nitrocellulose. This approach has the advantage that molecules can be immobilized directly without the need to create functional groups, and nitrocellulose has been previously shown to be a effective substrate for the immobilization of diverse glyans \[[@CR35], [@CR36]\]. Non-covalent attachment has the potential drawback that variations in the effectiveness of immobilization may result from differences in the structural properties of the arrayed molecules \[[@CR8]\]. All of the arrayed samples used in this work were recognized to some extent by at least one of the mAbs used (as shown in Fig. [4](#Fig4){ref-type="fig"}), indicating that all were immobilized to some degree. Nevertheless, the spot signals obtained can only provide semi-quantitative information about mAb binding.

Two new probes, LM13 and LM14 were produced against cell wall polymers and both have distinctly different specificities to previously generated antibodies. Cluster analysis, ciELISA data immunoblotting and arabinanase sensitivity suggested that the epitope recognized by LM13 is an arabinan-containing structure that occurs as a side chain on pectic polymers. Pectic side chains typically consist of either galactan, arabinan or type I arabinogalactan chains in which arabinose usually occurs as a terminal sugar \[[@CR18]\]. It was of note that LM13 binding to arrays was reduced to some extent by galactanase digestion. However, the galactanase used had very low arabinanase side activity (\<0.03 U/ml specific activity with an arabinan substrate compared to 780 U/ml specific activity with a galactan substrate). It is possible therefore that galactanase digestion resulted in the indirect loss of the LM13 epitope by cleavage of galactan to which an arabinan-containing epitope is attached. The fact that LM14 bound to both pectin-derived MHR samples and to AGP-like material on a blot suggests that this mAb binds to an epitope of type II arabinogalactan that may occur on both pectins and AGPs. The novel patterns of recognition on *A. thaliana* and other plant materials indicates that these are useful new probes for the analysis of cell wall glycans polymers and complex cell wall architectures.
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